Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas

Li,Jinzhong; Chen,Ning; Gong,Xiaobing

doi:10.3892/mmr.2019.10771

Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas

Authors:
- Jinzhong Li
- Ning Chen
- Xiaobing Gong
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510000, P.R. China, Department of General Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510000, P.R. China
Published online on: October 25, 2019 https://doi.org/10.3892/mmr.2019.10771
Pages: 5304-5314

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

RNA‑Sequencing and methylation data for hepatocellular carcinoma (HCC) were downloaded from The Cancer Genome Atlas (TCGA). The aberrantly expressed methylation‑driven genes in HCC and normal tissues were identified using the Limma package and the MethylMix algorithm. The Database for Annotation, Visualization and Integrated Discovery and ConsensusPathDB were used for Gene Ontology (GO) enrichment and pathway analysis. Univariate and multivariate Cox regression analyses were used to construct a prognostic risk model of HCC. Survival curve and receiver operating characteristic (ROC) curves were applied to evaluate the clinical utility of the risk model. A total of 238 methylation‑driven genes were successfully identified from cancer and normal tissues. GO enrichment analysis indicated that these genes functioned in the extracellular space, interfering with lipid metabolism in hepatocytes and regulating adaptive immune responses. In total, 14 relevant pathways were identified. The following prognostic risk model was generated: Risk score=CALML3 (degree of methylation) x (‑4.860) + CCNI2 x (2.071) + TNFRSF12A x (‑3.369) + IFITM1 x (1.203) + ENPP7P13 x (‑1.366) + DDT x (2.139) + RASAL2‑AS1 x (‑1.384) + ANKRD22 x (‑3.215). The median risk score (0.970) derived from this model was set as cutoff value for assigning patients to high‑ or low‑risk group. The 5‑year survival rate was 35.8% [95% confidence interval (CI)=27.1‑47.4%] in the high‑risk group and 61.7% (95% CI=51.4‑74.2%) in the low‑risk group (P<0.0001). The ROC curve showed an area under the curve of 0.742, indicating that this model is appropriate for predicting the survival rate of patients. Furthermore, the methylation and expression levels of two key genes, tumor necrosis factor superfamily member 12A and D‑dopachrome decarboxylase, were significantly associated with prognosis and were correlated with cg00510447, cg26808293, cg11060661 and cg16132339 methylation. In conclusion, a prognostic risk model for HCC is proposed based on the bioinformatic analysis of methylation‑driven genes. The findings of the present study may improve understanding of the pathogenesis and prognosis of HCC.

View Figures

View References

1	McGlynn KA, Petrick JL and London WT: Global epidemiology of hepatocellular carcinoma: An emphasis on demographic and regional variability. Clin Liver Dis. 19:223–238. 2015. View Article : Google Scholar : PubMed/NCBI
2	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
3	Shen H and Laird PW: Interplay between the cancer genome and epigenome. Cell. 153:38–55. 2013. View Article : Google Scholar : PubMed/NCBI
4	Kanwal R, Gupta K and Gupta S: Cancer epigenetics: An introduction. Methods Mol Biol. 1238:3–25. 2015. View Article : Google Scholar : PubMed/NCBI
5	Yang IV and Schwartz DA: Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med. 183:1295–1301. 2011. View Article : Google Scholar : PubMed/NCBI
6	Widschwendter M, Jiang G, Woods C, Müller HM, Fiegl H, Goebel G, Marth C, Müller-Holzner E, Zeimet AG, Laird PW and Ehrlich M: DNA hypomethylation and ovarian cancer biology. Cancer Res. 64:4472–4480. 2004. View Article : Google Scholar : PubMed/NCBI
7	Yoder JA, Walsh CP and Bestor TH: Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:335–340. 1997. View Article : Google Scholar : PubMed/NCBI
8	Jones PA: Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet. 13:484–492. 2012. View Article : Google Scholar : PubMed/NCBI
9	Baylin SB and Chen WY: Aberrant gene silencing in tumor progression: Implications for control of cancer. Cold Spring Harb Symp Quant Biol. 70:427–433. 2005. View Article : Google Scholar : PubMed/NCBI
10	Jones PA and Baylin SB: The epigenomics of cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
11	Gao C, Zhuang J, Zhou C, Ma K, Zhao M, Liu C, Liu L, Li H, Feng F and Sun C: Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas. J Cell Physiol. 234:6519–6528. 2019. View Article : Google Scholar : PubMed/NCBI
12	Feng L and Jin F: Screening of differentially methylated genes in breast cancer and risk model construction based on TCGA database. Oncol Lett. 16:6407–6416. 2018.PubMed/NCBI
13	Udali S, Guarini P, Ruzzenente A, Ferrarini A, Guglielmi A, Lotto V, Tononi P, Pattini P, Moruzzi S, Campagnaro T, et al: DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma. Clin Epigenetics. 7:432015. View Article : Google Scholar : PubMed/NCBI
14	Zhong XY, Yuan XM, Xu YY, Yin M, Yan WW, Zou SW, Wei LM, Lu HJ, Wang YP and Lei QY: CARM1 methylates GAPDH to regulate glucose metabolism and is suppressed in liver cancer. Cell Rep. 24:3207–3223. 2018. View Article : Google Scholar : PubMed/NCBI
15	Zhang H, Nie W and Huang F: The correlation relationship between P14ARF gene DNA methylation and primary liver cancer. Med Sci Monit. 21:3077–3082. 2015. View Article : Google Scholar : PubMed/NCBI
16	Tomczak K, Czerwińska P and Wiznerowicz M: The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
17	Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI
18	Singh R and Mukhopadhyay K: Survival analysis in clinical trials: Basics and must know areas. Perspect Clin Res. 2:145–148. 2011. View Article : Google Scholar : PubMed/NCBI
19	Zhang CB, Zhu P, Yang P, Cai JQ, Wang ZL, Li QB, Bao ZS, Zhang W and Jiang T: Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling. Oncotarget. 6:36643–36651. 2015.PubMed/NCBI
20	Chan SL, Wong VW, Qin S and Chan HL: Infection and cancer: The case of Hepatitis B. J Clin Oncol. 34:83–90. 2016. View Article : Google Scholar : PubMed/NCBI
21	Wallace MC, Preen D, Jeffrey GP and Adams LA: The evolving epidemiology of hepatocellular carcinoma: A global perspective. Expert Rev Gastroenterol Hepatol. 9:765–779. 2015. View Article : Google Scholar : PubMed/NCBI
22	Tian Y, Wong WS, Chan LY and Cheng AS: Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Semin Cancer Biol. 23:471–482. 2013. View Article : Google Scholar : PubMed/NCBI
23	Kalhan SC, Edmison J, Marczewski S, Dasarathy S, Gruca LL, Bennett C, Duenas C and Lopez R: Methionine and protein metabolism in non-alcoholic steatohepatitis: Evidence for lower rate of transmethylation of methionine. Clin Sci (Lond). 121:179–189. 2011. View Article : Google Scholar : PubMed/NCBI
24	Niculescu MD and Zeisel SH: Diet, methyl donors and DNA methylation: Interactions between dietary folate, methionine and choline. J Nutr. 132 (8 Suppl):2333S–2335S. 2002. View Article : Google Scholar : PubMed/NCBI
25	Tryndyak VP, Han T, Muskhelishvili L, Fuscoe JC, Ross SA, Beland FA and Pogribny IP: Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet. Mol Nutr Food Res. 55:411–418. 2011. View Article : Google Scholar : PubMed/NCBI
26	Pogribny IP, James SJ and Beland FA: Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency. Mol Nutr Food Res. 56:116–125. 2012. View Article : Google Scholar : PubMed/NCBI
27	Bruix J, Gores GJ and Mazzaferro V: Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut. 63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
28	Jones PA and Takai D: The role of DNA methylation in mammalian epigenetics. Science. 293:1068–1070. 2001. View Article : Google Scholar : PubMed/NCBI
29	Karpf AR and Jones DA: Reactivating the expression of methylation silenced genes in human cancer. Oncogene. 21:5496–5503. 2002. View Article : Google Scholar : PubMed/NCBI
30	Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA and Fanslow WC: A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity. 15:837–846. 2001. View Article : Google Scholar : PubMed/NCBI
31	Wang T, Ma S, Qi X, Tang X, Cui D, Wang Z, Chi J, Li P and Zhai B: Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro. Mol Med Rep. 15:1172–1178. 2017. View Article : Google Scholar : PubMed/NCBI
32	Yang J, Min KW, Kim DH, Son BK, Moon KM, Wi YC, Bang SS, Oh YH, Do SI, Chae SW, et al: High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts. PLoS One. 13:e02021132018. View Article : Google Scholar : PubMed/NCBI
33	O'Reilly C, Doroudian M, Mawhinney L and Donnelly SC: Targeting MIF in cancer: Therapeutic strategies, current developments, and future opportunities. Med Res Rev. 36:440–460. 2016. View Article : Google Scholar : PubMed/NCBI
34	Coleman AM, Rendon BE, Zhao M, Qian MW, Bucala R, Xin D and Mitchell RA: Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase. J Immunol. 181:2330–2337. 2008. View Article : Google Scholar : PubMed/NCBI
35	O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 445:106–110. 2007. View Article : Google Scholar : PubMed/NCBI
36	Wang M, Xiao J, Shen M, Yahong Y, Tian R, Zhu F, Jiang J, Du Z, Hu J, Liu W and Qin R: Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties. Int J Cancer. 128:72–81. 2011. View Article : Google Scholar : PubMed/NCBI
37	Klepin HD: Myelodysplastic syndromes and acute myeloid leukemia in the elderly. Clin Geriat Med. 32:155–173. 2016. View Article : Google Scholar
38	Zhou L, Cheng X, Connolly BA, Dickman MJ, Hurd PJ and Hornby DP: Zebularine: A novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol. 321:591–599. 2002. View Article : Google Scholar : PubMed/NCBI
39	Andersen JB, Factor VM, Marquardt JU, Raggi C, Lee YH, Seo D, Conner EA and Thorgeirsson SS: An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer. Sci Transl Med. 2:54ra772010. View Article : Google Scholar : PubMed/NCBI
40	Hou XJ, Zhao QD, Jing YY, Han ZP, Yang X, Wei LX, Zheng YT, Xie F and Zhang BH: Methylation mediated Gadd45β enhanced the chemosensitivity of hepatocellular carcinoma by inhibiting the stemness of liver cancer cells. Cell Biosci. 7:632017. View Article : Google Scholar : PubMed/NCBI
41	Cheng Z, Yunfei P, Fan Y, Qin R, Liu W and Zhang C: PCDH8 is frequently inactivated by promoter hypermethylation in liver cancer: Diagnostic and clinical significance. J Cancer. 7:446–452. 2016. View Article : Google Scholar : PubMed/NCBI
42	Tao R, Li J, Xin J, Wu J, Guo J, Zhang L, Jiang L, Zhang W, Yang Z and Li L: Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma. PLoS One. 6:e198622011. View Article : Google Scholar : PubMed/NCBI
43	Fan G, Tu Y, Chen C, Sun H, Wan C and Cai X: DNA methylation biomarkers for hepatocellular carcinoma. Cancer Cell Int. 18:1402018. View Article : Google Scholar : PubMed/NCBI
44	Zeidler R, de Freitas Soares BL, Bader A and Giri S: Molecular epigenetic targets for liver diseases: Current challenges and future prospects. Drug Discov Today. 22:1620–1636. 2017. View Article : Google Scholar : PubMed/NCBI